Paxerolâ„¢ for Treatment of Nocturia - A Phase II Placebo-Controlled Trial
Phase 2
Completed
- Conditions
- Nocturia
- Interventions
- Other: PlaceboDrug: Paxerol - Dose Level 1Drug: Paxerol - Dose Level 2Drug: Paxerol - Dose Level 3
- First Posted Date
- 2016-01-06
- Last Posted Date
- 2019-06-14
- Lead Sponsor
- Wellesley Pharmaceuticals, LLC
- Target Recruit Count
- 86
- Registration Number
- NCT02646826
- Locations
- 🇺🇸
The Westchester Medical Group PC, Harrison, New York, United States
🇺🇸Washington High Urology, New York, New York, United States
🇺🇸Dr. George Klein, New York, New York, United States
© Copyright 2025. All Rights Reserved by MedPath